Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover
- PMID: 12957219
- DOI: 10.1016/s0091-3057(03)00150-3
Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover
Abstract
Large doses (10-40 mg/kg) of the selective cannabinoid CB(1) receptor antagonist, SR 141716A, produce the head-twitch response (HTR) and scratching in rodents and vomiting in the least shrew (Cryptotis parva). Agents that increase brain serotonin (5-HT) levels induce the HTR in rodents, whereas enhancements in either brain 5-HT or dopamine concentrations can lead to production of emesis in vomiting species. The present study was undertaken to demonstrate whether large doses of SR 141716A can (1) induce the HTR and scratching in the least shrew and (2) cause concurrent biochemical changes in brain 5-HT and dopamine concentrations. SR 141716A (0, 1, 5, 10, 20 and 40 mg/kg i.p.) administration induced the HTR, scratching and vomiting. The HTR effect was bell shaped with a maximum frequency occurring at the 20 mg/kg SR 141716A dose, whereas the scratching and vomiting behaviors displayed dose-dependent effects. The selective 5-HT(2A/C) receptor antagonist, SR 46349B (0, 0.1, 0.25, 1, 3 and 6 mg/kg i.p.), differentially attenuated all SR 141716A (20 mg/kg)-induced behaviors because the HTR was relatively more potently and completely blocked. In the shrew forebrain, SR 141716A (20 and 40 mg/kg ip) caused dose- and time-dependent increases in the levels of 5-HT and dopamine and the concentrations of their major metabolites [5-hydroxyindole acetic acid (5-HIAA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanilic acid (HVA)] and the turnover of both monoamines. Although the effects of SR 141716A on brainstem concentrations of both monoamines and their metabolites were not always consistent, the CB(1) antagonist did increase the turnover of both 5-HT and dopamine. The present findings suggest that the mechanism and the neurochemical substrate for SR 141716A-induced HTR and scratching behaviors is enhancement of 5-HT release, whereas increased release of 5-HT and dopamine probably contributes to the production of emesis.
Similar articles
-
Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.Eur J Pharmacol. 2004 Mar 19;488(1-3):201-12. doi: 10.1016/j.ejphar.2004.02.018. Eur J Pharmacol. 2004. PMID: 15044052
-
Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice.J Neural Transm (Vienna). 2000;107(8-9):931-45. doi: 10.1007/s007020070043. J Neural Transm (Vienna). 2000. PMID: 11041273
-
Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.Neuropsychopharmacology. 2001 Feb;24(2):198-203. doi: 10.1016/S0893-133X(00)00197-4. Neuropsychopharmacology. 2001. PMID: 11120402
-
Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.Pharmacol Biochem Behav. 2002 Jan-Feb;71(1-2):155-62. doi: 10.1016/s0091-3057(01)00647-5. Pharmacol Biochem Behav. 2002. PMID: 11812518
-
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.Life Sci. 1999;65(6-7):627-35. doi: 10.1016/s0024-3205(99)00285-4. Life Sci. 1999. PMID: 10462063 Review.
Cited by
-
Involvement of cannabinoid receptors in gut motility and visceral perception.Br J Pharmacol. 2004 Apr;141(8):1335-45. doi: 10.1038/sj.bjp.0705783. Br J Pharmacol. 2004. PMID: 15100166 Free PMC article. Review.
-
Motor-like Tics are Mediated by CB2 Cannabinoid Receptor-dependent and Independent Mechanisms Associated with Age and Sex.Mol Neurobiol. 2022 Aug;59(8):5070-5083. doi: 10.1007/s12035-022-02884-6. Epub 2022 Jun 6. Mol Neurobiol. 2022. PMID: 35666403 Free PMC article.
-
Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in C. elegans.J Neurosci. 2019 May 22;39(21):4142-4152. doi: 10.1523/JNEUROSCI.2371-18.2019. Epub 2019 Mar 18. J Neurosci. 2019. PMID: 30886012 Free PMC article.
-
Modulation of the serotonin system by endocannabinoid signaling.Neuropharmacology. 2011 Sep;61(3):414-20. doi: 10.1016/j.neuropharm.2011.02.016. Epub 2011 Feb 24. Neuropharmacology. 2011. PMID: 21354188 Free PMC article. Review.
-
Cannabinoid-Induced Hyperemesis: A Conundrum-From Clinical Recognition to Basic Science Mechanisms.Pharmaceuticals (Basel). 2010 Jul 7;3(7):2163-2177. doi: 10.3390/ph3072163. Pharmaceuticals (Basel). 2010. PMID: 27713347 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials